[1]Patent:WO2018/194885,2018,A1.Locationinpatent:Page/Pagecolumn19
[2]JournalofMedicinalChemistry,1974,vol.17,p.34-41
[1]ChemCatChem,2016,vol.8,p.2630-2633
132741-31-2
132741-29-8
207853-61-0
207974-19-4
261951-74-0
658-93-5
387358-41-0 | 1,2,3,4-Tetrahydropyrido[4,3-b][1,8]naphthyridine | AA00C84K | MFCD28388234
41717-26-4 | 1-(2,4,6-Trimethylbenzyl)piperazine | AA00C889 | MFCD03094587
350997-69-2 | 3-(3,4-Dimethoxyphenyl)-1h-pyrazole-4-carbaldehyde | AA00C8C0 | MFCD01924091
39494-07-0 | 3-Chloro-n-(2,5-dimethylphenyl)propanamide | AA00C8GM | MFCD01338783
35266-48-9 | N1-(2-AMINOPHENYL)-N2,N2-DIMETHYLGLYCINAMIDE | AA00C8KX | MFCD09731069
40373-88-4 | 2-(4-Chlorophenyl)-3-(dimethylamino)acrylonitrile | AA00C8OR | MFCD00138415
34176-47-1 | 5-Ethyl-4-phenyl-1,3-thiazol-2-amine | AA00C8TK | MFCD00736900
321132-21-2 | 1-(4-Benzyloxyphenyl)piperazine, HCl | AA00C8X3 | MFCD00191210
357336-20-0 | brivaracetam | AA00C92K | MFCD13152385
3869-32-7 | (6,11,16a)-9-Fluoro-6,11,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione | AA00C997